Mycophenolate Mofetil Selection of Gene Modified T Cells With an Engineered Human Inosine Monophosphate Dehydrogenase II (IMPDH2)

被引：0
|
作者：
Jonnalagadda, Mahesh [1 ]
Chang, Wen-Chung [1 ]
Jensen, Michael C. [1 ]
机构：
[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2008年 / 31卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：923 / 923
页数：1
相关论文
共 34 条
  • [1] Interpopulation Variation Frequency of Human Inosine 5′-Monophosphate Dehydrogenase Type II (IMPDH2) Genetic Polymorphisms
    Mohamed, Mohamed-Eslam F.
    Frye, Reginald F.
    Langaee, Taimour Y.
    GENETIC TESTING, 2008, 12 (04): : 513 - 516
  • [2] Novel roles of Inosine Monophosphate Dehydrogenase 2 (IMPDH2) in TNBC doxorubicin resistance
    Fernandes, Tatiane da Silva
    Bianchi-Smiraglia, Anna
    CANCER RESEARCH, 2023, 83 (05)
  • [3] Assignment of inosine 5′-monophosphate dehydrogenase type 2(IMPDH2) to human chromosome band 3p21.2 by in situ hybridization
    Kost-Alimova, MV
    Glesne, DA
    Huberman, E
    Zelenin, AV
    CYTOGENETICS AND CELL GENETICS, 1998, 82 (3-4): : 145 - 146
  • [4] CHROMOSOMAL LOCALIZATION AND STRUCTURE OF THE HUMAN TYPE-II IMP DEHYDROGENASE GENE (IMPDH2)
    GLESNE, D
    COLLART, F
    VARKONY, T
    DRABKIN, H
    HUBERMAN, E
    GENOMICS, 1993, 16 (01) : 274 - 277
  • [5] Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics
    Wu, T-Y
    Peng, Y.
    Pelleymounter, L. L.
    Moon, I.
    Eckloff, B. W.
    Wieben, E. D.
    Yee, V. C.
    Weinshilboum, R. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1584 - 1598
  • [6] Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer
    Tatiane da Silva Fernandes
    Bryan M. Gillard
    Tao Dai
    Jeffrey C. Martin
    Kanita A. Chaudhry
    Scott M. Dugas
    Alyssa A. Fisher
    Pia Sharma
    RongRong Wu
    Kristopher M. Attwood
    Subhamoy Dasgupta
    Kazuaki Takabe
    Spencer R. Rosario
    Anna Bianchi-Smiraglia
    Scientific Reports, 15 (1)
  • [7] Measurement of inosine 5′-monophosphate dehydrogenase activity in peripheral mononuclear cells for pharmacodynamic monitoring of mycophenolate mofetil
    Bonner, HS
    Shaw, LM
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 508 - 508
  • [8] Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil
    Gensburger, Olivier
    Van Schaik, Ron H. N.
    Picard, Nicolas
    Le Meur, Yannick
    Rousseau, Annick
    Woillard, Jean-Baptiste
    Van Gelder, Teun
    Marquet, Pierre
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (09): : 537 - 543
  • [9] The expression and characterization of up-regulated inosine monophosphate dehydrogenase type 2 (IMPDH2) in colorectal adenocarcinoma tissues by proteomic analysis
    Shim, Doobo
    Kang, Jung H.
    Park, Eun S.
    Kang, Kee R.
    CANCER RESEARCH, 2010, 70
  • [10] The expression and characterization of up-regulated inosine monophosphate dehydrogenase type 2 (IMPDH2) in colorectal adenocarcinoma tissues by proteomic analysis
    Shim, Doobo
    Kang, Jung H.
    Park, Eun S.
    Kang, Kee R.
    CANCER RESEARCH, 2010, 70
1234